- Home
- CTHR vs APM Comparison
CTHR vs APM Comparison
Compare CTHR & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTHR
- APM
- Stock Information
- Founded
- CTHR 1995
- APM 2010
- Country
- CTHR United States
- APM United Kingdom
- Employees
- CTHR N/A
- APM N/A
- Industry
- CTHR Consumer Specialties
- APM Biotechnology: Pharmaceutical Preparations
- Sector
- CTHR Consumer Discretionary
- APM Health Care
- Exchange
- CTHR Nasdaq
- APM Nasdaq
- Market Cap
- CTHR 4.1M
- APM 4.1M
- IPO Year
- CTHR 1997
- APM 2018
- Fundamental
- Price
- CTHR $1.52
- APM $1.15
- Analyst Decision
- CTHR
- APM
- Analyst Count
- CTHR 0
- APM 0
- Target Price
- CTHR N/A
- APM N/A
- AVG Volume (30 Days)
- CTHR 24.6K
- APM 7.0M
- Earning Date
- CTHR 02-11-2025
- APM 12-20-2024
- Dividend Yield
- CTHR N/A
- APM N/A
- EPS Growth
- CTHR N/A
- APM N/A
- EPS
- CTHR N/A
- APM 0.00
- Revenue
- CTHR $23,684,860.00
- APM N/A
- Revenue This Year
- CTHR $31.82
- APM $157,729.10
- Revenue Next Year
- CTHR N/A
- APM N/A
- P/E Ratio
- CTHR N/A
- APM $345.64
- Revenue Growth
- CTHR N/A
- APM N/A
- 52 Week Low
- CTHR $1.16
- APM $0.46
- 52 Week High
- CTHR $4.90
- APM $17.49
- Technical
- Relative Strength Index (RSI)
- CTHR 55.10
- APM 47.12
- Support Level
- CTHR $1.36
- APM $1.21
- Resistance Level
- CTHR $1.56
- APM $1.30
- Average True Range (ATR)
- CTHR 0.10
- APM 0.75
- MACD
- CTHR 0.01
- APM -0.06
- Stochastic Oscillator
- CTHR 80.04
- APM 4.58
About CTHR Charles & Colvard Ltd
Charles & Colvard Ltd manufactures, markets, and distributes finished jewellery which also includes moissanite gemstone in the jewellery market. The company sells jewels through two operating segments namely Online Channels segment and Traditional segment. It generates maximum revenue from the Online Channels segment. Online Channels segment which consists of e-commerce outlets including charlesandcolvard.com, moissaniteoutlet.com, third-party online marketplaces, drop-ship retail, and other pure-play, exclusively e-commerce outlets.
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.